We have a diverse range of Australian companies in our portfolio. We have no constraints on the size of our shareholding or the minimum or maximum we are able to invest. However when combined with our co-investors, we generally hold majority positions in our investee companies.

Exciting to see Ondek is in track for human trials for its revolutionary childhood allergy therapeutic product Immbalance

Even Nobel Prize winners need to tap capital markets occasionally.

Australian physician Barry Marshall, who received the award in 2005 for discovering the bacteria Helicobacter pylori, has raised $3.59 million for his biotechnology company Ondek.

Dymocks Group chairman John Forsyth and Perth-based founder of construction and property company ABN Group, Dale Alcock, were among high-profile investors who tipped into the raise.

This entry was posted on Monday, July 10th, 2017 and is filed under Ondek. Read all posts published by
Arrow down

News, articles
& white papers


Exto Partners Pty Ltd
ABN 38 104 130 636

Office Address:
Suite 302 / 19a Boundary Street
Rushcutters Bay, NSW 2011

Phone: +61 2 9332 0600

View on Google maps
Arrow down Contact Expo Partners